# Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years With Major Depressive Disorder (MDD)

> **NCT02709746** · PHASE3 · COMPLETED · sponsor: **H. Lundbeck A/S** · enrollment: 784 (actual)

## Conditions studied

- Depressive Disorder, Major

## Interventions

- **DRUG:** Vortioxetine 10 mg/day
- **DRUG:** Vortioxetine 20 mg/day
- **DRUG:** Fluoxetine 20 mg/day
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02709746
- **Lead sponsor:** H. Lundbeck A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05
- **Primary completion:** 2019-07-02
- **Final completion:** 2019-07-30
- **Target enrollment:** 784 (ACTUAL)
- **Last updated:** 2020-08-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02709746

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02709746, "Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years With Major Depressive Disorder (MDD)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02709746. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*